Physician profile
Austin Bohner
NPI 1770111775
$2,980.36
in general payments reported to CMS, 2019-2025
8 companies · $1,306 in 2025
The $1,306 reported for 2025 was more than what 83% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.45 · 2022: $124 · 2023: $757 · 2024: $749 · 2025: $1,306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,811.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,379.03 | 2023-2025 | Hydrus Microstent, Clareon |
| Glaukos Corporation | $450.46 | 2022-2025 | Idosetr, Istent Trabecular Micro-Bypass System Model Is3, Istent Infinite |
| New World Medical,INC. | $432.88 | 2024-2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Streamline |
| Abbvie INC. | $356.09 | 2023-2025 | |
| Sight Sciences, INC. | $193.85 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Bausch & Lomb Americas INC. | $99.64 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $45.45 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $22.96 | 2025 | Tecnis Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Bohner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.